Literature DB >> 28302515

Orodispersible films: Towards drug delivery in special populations.

Mariagiovanna Scarpa1, Sven Stegemann2, Wen-Kai Hsiao3, Heinz Pichler3, Simon Gaisford1, Massimo Bresciani3, Amrit Paudel4, Mine Orlu1.   

Abstract

Orodispersible films (ODF) hold promise as a novel delivery method, with the potential to deliver tailored therapies to different patient populations. This article reviews the current strides of ODF technology and some of its unmet quality and manufacturing aspects. A topic highlights opportunities and limitations of inkjet printed ODF as a population-specific drug delivery. Overall, this article aims to stimulate further research to fill the current knowledge gap between manufacturing and administration requirements of ODF targeting specific patient subpopulations such as geriatrics.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acceptability; Disintegration; Drop-on-demand; Inkjet printing; Orodispersible film; Substrate

Mesh：

Substances：

Year:  2017        PMID： 28302515     DOI： 10.1016/j.ijpharm.2017.03.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN： 0378-5173            Impact factor:   5.875


  14 in total

1.  Neoteric Approach of Fluoxetine Laden Orodispersible Film for Non-compliant Pediatric Patients of Selective Mutism and Obsessive-compulsive Disorder.

Authors:  Haseeb Anwar Dad; Asra Shanzeh Shabbir; Saman Ali; Tariq Mahmood
Journal:  Turk J Pharm Sci       Date:  2021-12-31

2.  Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study.

Authors:  J Carolina Visser; Lisa Wibier; Marina Mekhaeil; Herman J Woerdenbag; Katja Taxis
Journal:  Int J Clin Pharm       Date:  2020-02-13

3.  A Focus Group Study about Oral Drug Administration Practices at Hospital Wards-Aspects to Consider in Drug Development of Age-Appropriate Formulations for Children.

Authors:  Maria Rautamo; Kirsi Kvarnström; Mia Sivén; Marja Airaksinen; Pekka Lahdenne; Niklas Sandler
Journal:  Pharmaceutics       Date:  2020-01-30       Impact factor: 6.321

4.  Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.

Authors:  Irma Elisa Cupone; Eleonora Dellera; Fabio Marra; Andrea Maria Giori
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

5.  Comparative Bioavailability Study of a New Vitamin D3 Orodispersible Film Versus a Marketed Oral Solution in Healthy Volunteers.

Authors:  Milko Radicioni; Carol Caverzasio; Stefano Rovati; Andrea Maria Giori; Irma Cupone; Fabio Marra; Giuseppe Mautone
Journal:  Clin Drug Investig       Date:  2022-01-16       Impact factor: 2.859

6.  Effects of Various Drying Times on the Properties of 3D Printed Orodispersible Films.

Authors:  Natália Janigová; Jan Elbl; Sylvie Pavloková; Jan Gajdziok
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

7.  New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate.

Authors:  Sahar Salehi; Soheil Boddohi
Journal:  Prog Biomater       Date:  2017-11-06

Review 8.  Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.

Authors:  Enrica Menditto; Valentina Orlando; Giuseppe De Rosa; Paola Minghetti; Umberto Maria Musazzi; Caitriona Cahir; Marta Kurczewska-Michalak; Przemysław Kardas; Elísio Costa; José Manuel Sousa Lobo; Isabel F Almeida
Journal:  Pharmaceutics       Date:  2020-01-03       Impact factor: 6.321

9.  Orodispersible Films with Rupatadine Fumarate Enclosed in Ethylcellulose Microparticles as Drug Delivery Platform with Taste-Masking Effect.

Authors:  Katarzyna Olechno; Bartosz Maciejewski; Klaudia Głowacz; Joanna Lenik; Patrycja Ciosek-Skibińska; Anna Basa; Katarzyna Winnicka
Journal:  Materials (Basel)       Date:  2022-03-14       Impact factor: 3.623

10.  Near-Infrared Hyperspectral Imaging as a Monitoring Tool for On-Demand Manufacturing of Inkjet-Printed Formulations.

Authors:  Sandra Stranzinger; Matthias Wolfgang; Emma Klotz; Otto Scheibelhofer; Patrizia Ghiotti; Johannes G Khinast; Wen-Kai Hsiao; Amrit Paudel
Journal:  AAPS PharmSciTech       Date:  2021-08-10       Impact factor: 3.246
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.